|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8,630.00 KRW | -1.93% |
|
-3.36% | -23.36% |
Company Valuation: Englewood Lab, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 99,141 | 170,864 | 101,127 | 264,839 | 135,499 | 223,712 |
| Change | - | 72.34% | -40.81% | 161.89% | -48.84% | 65.1% |
| Enterprise Value (EV) 1 | 111,906 | 189,873 | 115,151 | 259,973 | 127,057 | 200,892 |
| Change | - | 69.67% | -39.35% | 125.77% | -51.13% | 58.11% |
| P/E | 32.2x | 11.4x | 13.9x | 12.8x | 6.9x | 9.02x |
| PBR | 1.63x | 2.11x | 1.09x | 2.3x | 0.94x | 1.36x |
| PEG | - | 0x | -0.3x | 0x | -1.28x | 0.3x |
| Capitalization / Revenue | 0.72x | 1.06x | 0.67x | 1.28x | 0.74x | 1.03x |
| EV / Revenue | 0.82x | 1.18x | 0.76x | 1.26x | 0.7x | 0.93x |
| EV / EBITDA | 9.09x | 8.95x | 8.09x | 7.82x | 5.31x | 4.72x |
| EV / EBIT | 14.2x | 11.2x | 11.7x | 9.01x | 6.76x | 5.38x |
| EV / FCF | 24.2x | -11.3x | 493x | 16.7x | -26.8x | 20x |
| FCF Yield | 4.13% | -8.85% | 0.2% | 6% | -3.73% | 5% |
| Dividend per Share 2 | - | - | - | - | 100 | 201 |
| Rate of return | - | - | - | - | 1.47% | 1.79% |
| EPS 2 | 155.1 | 754.9 | 365.7 | 1,044 | 987.9 | 1,249 |
| Distribution rate | - | - | - | - | 10.1% | 16.1% |
| Net sales 1 | 137,168 | 160,816 | 151,509 | 206,784 | 182,220 | 216,790 |
| EBITDA 1 | 12,307 | 21,209 | 14,230 | 33,249 | 23,912 | 42,601 |
| EBIT 1 | 7,869 | 16,905 | 9,882 | 28,855 | 18,795 | 37,368 |
| Net income 1 | 3,082 | 14,997 | 7,265 | 20,742 | 19,628 | 24,815 |
| Net Debt 1 | 12,766 | 19,010 | 14,023 | -4,865 | -8,442 | -22,820 |
| Reference price 2 | 4,990.00 | 8,600.00 | 5,090.00 | 13,330.00 | 6,820.00 | 11,260.00 |
| Nbr of stocks (in thousands) | 19,868 | 19,868 | 19,868 | 19,868 | 19,868 | 19,868 |
| Announcement Date | 17/3/21 | 16/3/22 | 15/3/23 | 21/3/24 | 20/3/25 | 16/3/26 |
1KRW in Million2KRW
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 116M | ||
| 28.89x | 4.51x | 18.66x | 2.03% | 232B | ||
| 58.27x | 8.23x | 32.07x | 0.26% | 50.71B | ||
| 26.62x | 5.02x | 18.95x | 1.18% | 9.55B | ||
| 27.1x | 1.32x | 10.17x | 2.15% | 6.85B | ||
| 21.53x | 1.52x | 9.67x | 1.29% | 5.08B | ||
| 39.18x | 2.61x | 12.88x | -.--% | 4.41B | ||
| 23.83x | 2.34x | 12.21x | 2.77% | 3.7B | ||
| 14.37x | 1.59x | 8.85x | 3.02% | 3.34B | ||
| 19.91x | 2.46x | 12.02x | 3.86% | 2.56B | ||
| Average | 28.86x | 3.29x | 15.05x | 1.84% | 31.8B | |
| Weighted average by Cap. | 33.21x | 4.91x | 20.17x | 1.72% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- A950140 Stock
- Valuation Englewood Lab, Inc.
Select your edition
All financial news and data tailored to specific country editions
















